Moreover, patients with high UBE2C protein expression showed a significant poor 10 years BC disease-free survival (BCDFS) (p = 0.019, HR = 1.43, 95% CI; 1.06–1.91; Fig. 3B). This evidence concerns the gene UBE2C and breast cancer.